Share This Author
Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population
- Liangdan Sun, F. Xiao, Xue-Jun Zhang
- BiologyNature Genetics
- 1 July 2011
TLDR
Prevalence of Atopic Dermatitis in Chinese Children aged 1–7 ys
- Yifeng Guo, Ping Li, Z. Yao
- MedicineScientific reports
- 19 July 2016
TLDR
Clinical patterns and characteristics of ankylosing spondylitis in China
- Q. Qian, Xia Xu, Jiucun Wang
- MedicineClinical Rheumatology
- 27 May 2017
TLDR
A Retrospective Study of Propranolol Therapy in 635 Infants with Infantile Hemangioma
- Yongqi Luo, Ying-Hong Zeng, Bin Zhou, Jian-ping Tang
- MedicinePediatric dermatology
- 2015
Six hundred thirty‐five patients underwent oral propranolol treatment for infantile hemangioma. The efficacy rate was 91.2% and 162 of the patients recovered completely. No significant adverse…
Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia
- S. Banerjee, Dongzhu Lei, Jian-ping Tang
- Medicine, BiologyOncotarget
- 14 December 2016
TLDR
[Clinical features of onychomadesis following hand-foot-mouth disease in children].
- Jian-ping Tang, Mengye Hu, Zhu Wei
- MedicineZhongguo dang dai er ke za zhi = Chinese journal…
- 1 December 2014
Prolonging Time to Flare in Pediatric Atopic Dermatitis: A Randomized, Investigator-Blinded, Controlled, Multicenter Clinical Study of a Ceramide-Containing Moisturizer
- Lin Ma, Ping Li, N. Kerrouche
- MedicineAdvances in Therapy
- 16 November 2017
TLDR
Smoking quantity determines disease activity and function in Chinese patients with ankylosing spondylitis
- Hui Zhang, W. Wan, Jiucun Wang
- MedicineClinical Rheumatology
- 27 March 2018
TLDR
Marked Reduction of Sacroiliac Joint Inflammation on Magnetic Resonance Imaging in a Patient with Ankylosing Spondylitis After Rituximab Treatment
- Y. Huang, Fangyuan Cheng, Xiaoyu Zhang, Jian-ping Tang
- Medicine, BiologyThe Journal of Rheumatology
- 1 September 2011
TLDR
Phase 1 Study of TG-1701, a Selective Irreversible Inhibitor of Bruton's Tyrosine Kinase (BTK), in Patients with Relapsed/Refractory B-Cell Malignancies
- C. Cheah, N. Wickham, C. Tam
- MedicineBlood
- 13 November 2019
TLDR
...
...